Overview of COVID-19 individual participant data meta-analyses (IPD-MAs)
Description
Individual participant data meta-analyses (IPD-MAs), which include harmonising and analysing participant-level data from related studies, provide several advantages over aggregate data meta-analyses, which pool study-level findings. IPD-MAs inform the design and conduct of randomised clinical trials and have informed the research and public health responses to COVID-19. To identify areas of overlap, we conducted a rapid systematic review of completed or ongoing COVID-19 IPD-MAs. We identified 31 COVID-19 related IPD-MAs, including 5 living IPD-MAs, and found several areas of overlap in study designs, populations, exposures, and outcomes of interest. Details of the 31 identified COVID-19 IPD-MAs are presented in this dataset.
Resources
| Name |
Format |
Description |
Link |
|
0 |
|
http://data.europa.eu/88u/dataset/oai-zenodo-org-6623480 |
|
0 |
|
http://data.europa.eu/88u/dataset/oai-zenodo-org-6623480 |
Tags
- meta-analysis
- data-sharing
- individual-participant-data-meta-analysis
- covid-19